AAPL333.02+3.62 (+1.10%) ▲|ABBV261.59-1.70 (-0.65%) ▼|ABT98.83-2.12 (-2.10%) ▼|ACN183.37+6.25 (+3.53%) ▲|ADBE239.94+6.77 (+2.90%) ▲|AMAT511.38-0.63 (-0.12%) ▼|AMD611.76+4.19 (+0.69%) ▲|AMGN421.51-2.13 (-0.50%) ▼|AMT163.69-1.87 (-1.13%) ▼|AMZN249.15+2.48 (+1.01%) ▲|AVGO351.19-3.91 (-1.10%) ▼|AXP304.10-1.30 (-0.43%) ▼|BA186.05-1.63 (-0.87%) ▼|BAC54.43-0.53 (-0.96%) ▼|BKNG162.91+0.57 (+0.35%) ▲|BLK1,058.29-9.65 (-0.90%) ▼|BMY62.40-0.46 (-0.73%) ▼|BNY144.63-2.35 (-1.60%) ▼|BRK-B497.95-4.40 (-0.88%) ▼|C129.48-1.32 (-1.01%) ▼|CAT810.79-15.85 (-1.92%) ▼|CL85.32-1.14 (-1.32%) ▼|CMCSA21.76+0.16 (+0.74%) ▲|COF193.07-3.39 (-1.73%) ▼|COP125.15-0.29 (-0.23%) ▼|COST910.34-14.25 (-1.54%) ▼|CRM229.57+4.26 (+1.89%) ▲|CSCO107.63+0.69 (+0.65%) ▲|CVS85.69-1.41 (-1.62%) ▼|CVX204.21-0.17 (-0.08%) ▼|DE671.55-7.33 (-1.08%) ▼|DHR221.55-4.16 (-1.84%) ▼|DIS104.90-0.51 (-0.48%) ▼|DUK114.01-0.20 (-0.18%) ▼|EMR155.10-2.14 (-1.36%) ▼|FDX285.09-2.38 (-0.83%) ▼|GD331.83-0.51 (-0.15%) ▼|GE312.29-5.60 (-1.76%) ▼|GEV950.49-12.00 (-1.25%) ▼|GILD149.05-2.23 (-1.47%) ▼|GM77.00-3.47 (-4.31%) ▼|GOOG340.74+3.42 (+1.01%) ▲|GOOGL344.08+3.16 (+0.93%) ▲|GS900.36-15.88 (-1.73%) ▼|HD284.49-3.55 (-1.23%) ▼|HON210.94+0.81 (+0.39%) ▲|IBM219.93-0.06 (-0.03%) ▼|INTC120.23+4.30 (+3.71%) ▲|INTU275.71+7.68 (+2.87%) ▲|ISRG406.63-5.55 (-1.35%) ▼|JNJ264.74-2.83 (-1.06%) ▼|JPM330.83-4.15 (-1.24%) ▼|KO86.08-0.76 (-0.88%) ▼|LIN474.65+1.28 (+0.27%) ▲|LLY1,157.08-27.55 (-2.33%) ▼|LMT509.25-2.96 (-0.58%) ▼|LOW184.29-2.97 (-1.59%) ▼|LRCX328.51+4.65 (+1.44%) ▲|MA551.47-12.11 (-2.15%) ▼|MCD230.94-3.04 (-1.30%) ▼|MDLZ57.82-0.98 (-1.67%) ▼|MDT86.29-0.80 (-0.92%) ▼|META725.18-13.61 (-1.84%) ▼|MMM164.15-4.34 (-2.58%) ▼|MO67.34-1.38 (-2.01%) ▼|MRK145.31-3.97 (-2.66%) ▼|MS188.08-4.68 (-2.43%) ▼|MSFT512.90+3.94 (+0.77%) ▲|MU1,065.11+0.03 (+0.00%) ▲|NEE75.74-0.15 (-0.20%) ▼|NFLX69.58-0.72 (-1.02%) ▼|NKE35.40-0.44 (-1.23%) ▼|NOW134.01+4.07 (+3.13%) ▲|NVDA228.38+1.17 (+0.51%) ▲|ORCL137.30-0.49 (-0.36%) ▼|PEP126.72-1.97 (-1.53%) ▼|PFE28.52-0.20 (-0.70%) ▼|PG145.28-3.04 (-2.05%) ▼|PLTR187.05+0.08 (+0.04%) ▲|PM190.82-3.08 (-1.59%) ▼|QCOM184.04-0.06 (-0.03%) ▼|RTX185.65-1.29 (-0.69%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.89-0.56 (-0.67%) ▼|SPG200.76-3.52 (-1.72%) ▼|T24.40-0.08 (-0.33%) ▼|TMO675.05-4.56 (-0.67%) ▼|TMUS163.08+0.10 (+0.06%) ▲|TSLA354.81+1.97 (+0.56%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.08-7.86 (-2.10%) ▼|UNP272.13-2.02 (-0.74%) ▼|UPS93.44-0.49 (-0.52%) ▼|USB57.76+0.16 (+0.28%) ▲|V359.33-6.55 (-1.79%) ▼|VZ45.87-0.11 (-0.24%) ▼|WFC80.05-0.43 (-0.53%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.75+1.40 (+0.87%) ▲|AAPL333.02+3.62 (+1.10%) ▲|ABBV261.59-1.70 (-0.65%) ▼|ABT98.83-2.12 (-2.10%) ▼|ACN183.37+6.25 (+3.53%) ▲|ADBE239.94+6.77 (+2.90%) ▲|AMAT511.38-0.63 (-0.12%) ▼|AMD611.76+4.19 (+0.69%) ▲|AMGN421.51-2.13 (-0.50%) ▼|AMT163.69-1.87 (-1.13%) ▼|AMZN249.15+2.48 (+1.01%) ▲|AVGO351.19-3.91 (-1.10%) ▼|AXP304.10-1.30 (-0.43%) ▼|BA186.05-1.63 (-0.87%) ▼|BAC54.43-0.53 (-0.96%) ▼|BKNG162.91+0.57 (+0.35%) ▲|BLK1,058.29-9.65 (-0.90%) ▼|BMY62.40-0.46 (-0.73%) ▼|BNY144.63-2.35 (-1.60%) ▼|BRK-B497.95-4.40 (-0.88%) ▼|C129.48-1.32 (-1.01%) ▼|CAT810.79-15.85 (-1.92%) ▼|CL85.32-1.14 (-1.32%) ▼|CMCSA21.76+0.16 (+0.74%) ▲|COF193.07-3.39 (-1.73%) ▼|COP125.15-0.29 (-0.23%) ▼|COST910.34-14.25 (-1.54%) ▼|CRM229.57+4.26 (+1.89%) ▲|CSCO107.63+0.69 (+0.65%) ▲|CVS85.69-1.41 (-1.62%) ▼|CVX204.21-0.17 (-0.08%) ▼|DE671.55-7.33 (-1.08%) ▼|DHR221.55-4.16 (-1.84%) ▼|DIS104.90-0.51 (-0.48%) ▼|DUK114.01-0.20 (-0.18%) ▼|EMR155.10-2.14 (-1.36%) ▼|FDX285.09-2.38 (-0.83%) ▼|GD331.83-0.51 (-0.15%) ▼|GE312.29-5.60 (-1.76%) ▼|GEV950.49-12.00 (-1.25%) ▼|GILD149.05-2.23 (-1.47%) ▼|GM77.00-3.47 (-4.31%) ▼|GOOG340.74+3.42 (+1.01%) ▲|GOOGL344.08+3.16 (+0.93%) ▲|GS900.36-15.88 (-1.73%) ▼|HD284.49-3.55 (-1.23%) ▼|HON210.94+0.81 (+0.39%) ▲|IBM219.93-0.06 (-0.03%) ▼|INTC120.23+4.30 (+3.71%) ▲|INTU275.71+7.68 (+2.87%) ▲|ISRG406.63-5.55 (-1.35%) ▼|JNJ264.74-2.83 (-1.06%) ▼|JPM330.83-4.15 (-1.24%) ▼|KO86.08-0.76 (-0.88%) ▼|LIN474.65+1.28 (+0.27%) ▲|LLY1,157.08-27.55 (-2.33%) ▼|LMT509.25-2.96 (-0.58%) ▼|LOW184.29-2.97 (-1.59%) ▼|LRCX328.51+4.65 (+1.44%) ▲|MA551.47-12.11 (-2.15%) ▼|MCD230.94-3.04 (-1.30%) ▼|MDLZ57.82-0.98 (-1.67%) ▼|MDT86.29-0.80 (-0.92%) ▼|META725.18-13.61 (-1.84%) ▼|MMM164.15-4.34 (-2.58%) ▼|MO67.34-1.38 (-2.01%) ▼|MRK145.31-3.97 (-2.66%) ▼|MS188.08-4.68 (-2.43%) ▼|MSFT512.90+3.94 (+0.77%) ▲|MU1,065.11+0.03 (+0.00%) ▲|NEE75.74-0.15 (-0.20%) ▼|NFLX69.58-0.72 (-1.02%) ▼|NKE35.40-0.44 (-1.23%) ▼|NOW134.01+4.07 (+3.13%) ▲|NVDA228.38+1.17 (+0.51%) ▲|ORCL137.30-0.49 (-0.36%) ▼|PEP126.72-1.97 (-1.53%) ▼|PFE28.52-0.20 (-0.70%) ▼|PG145.28-3.04 (-2.05%) ▼|PLTR187.05+0.08 (+0.04%) ▲|PM190.82-3.08 (-1.59%) ▼|QCOM184.04-0.06 (-0.03%) ▼|RTX185.65-1.29 (-0.69%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.89-0.56 (-0.67%) ▼|SPG200.76-3.52 (-1.72%) ▼|T24.40-0.08 (-0.33%) ▼|TMO675.05-4.56 (-0.67%) ▼|TMUS163.08+0.10 (+0.06%) ▲|TSLA354.81+1.97 (+0.56%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.08-7.86 (-2.10%) ▼|UNP272.13-2.02 (-0.74%) ▼|UPS93.44-0.49 (-0.52%) ▼|USB57.76+0.16 (+0.28%) ▲|V359.33-6.55 (-1.79%) ▼|VZ45.87-0.11 (-0.24%) ▼|WFC80.05-0.43 (-0.53%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.75+1.40 (+0.87%) ▲|
19.7 C
New York
Thursday, October 1, 2026

globenewswire

Une première autorisation de distribution de la fleur de cannabis médicinal à des fins thérapeutiques délivrée par le ministère de la Santé italien pour...

SAVONE, Italie, 25 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ci-après « Tilray », une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique permettant aux patients comme aux professionnels de santé de prendre ensemble des décisions de santé individualisées éclairées, annonce ce jour un virage majeur dans son développement en Europe avec l’introduction de trois nouvelles variétés de fleur de cannabis thérapeutique en Italie. Via sa filiale en propriété exclusive FL Group, Tilray devient la première entreprise italienne à décrocher l’autorisation officielle du Ministero della Salute (le ministère italien de la Santé) d’importer et distribuer de la fleur de cannabis médicinal de la marque maison Tilray Medical à des fins thérapeutiques.

Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke

SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Zusammenarbeit zwischen Patienten und Ärzten fördert, um fundierte, individuelle Gesundheitsentscheidungen zu ermöglichen, hat heute einen bedeutenden Meilenstein in seiner Expansion in Europa bekanntgegeben: die Einführung von drei neuen medizinischen Cannabissorten in Italien. Über seine hundertprozentige Tochtergesellschaft FL Group ist Tilray das erste Unternehmen in Italien, das vom italienischen Gesundheitsministerium (Ministero della Salute) die offizielle Genehmigung für den Import und Vertrieb von medizinischem Cannabisblüten der Marke Tilray Medical für therapeutische Zwecke erhalten hat.

BloodVitals Pain-Free Blood Glucose Monitoring Device Launches to Support At-Home Wellness Tracking

Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.
Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.

Hewelth BioClear Launches as Breakthrough In-Home Laser Solution to Support Healthier Nail Appearance

Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use
Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use

Glokore Light Therapy Mask Earns Spotlight as Non-Invasive Red Light Skincare Solution Backed by User Satisfaction

LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data
LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data

VOSK Launches Sculptural Handmade Candle Collection, Elevating Ethical Decor for Modern Interiors

Vero Beach, Florida, June 24, 2025 (GLOBE NEWSWIRE) -- VOSK, an artisan candle brand, launches its collection of vegan handmade candles with unique sculptural designs. A family-owned small business in Florida, the brand introduces a fresh new take on ornamental candles.

House of Sillage Unveils “Superman”—A Fragrance that Honors the Duality of a Hero

House of Sillage releases the new Superman Fragrance in collaboration with WBDGCP to celebrate the upcoming film Superman, directed by James Gunn.

FLINT Announces Voting Results from Shareholders’ Meeting

CALGARY, Alberta, June 24, 2025 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT”) (TSX: FLNT) is pleased to announce that all matters presented for approval at its annual meeting (the "Meeting") of holders of common shares ("Common Shares") held earlier today were approved. A total of 24,877,170 Common Shares, representing approximately 22.62% of the issued and outstanding Common Shares, were represented at the Meeting.

Faircourt Asset Management Inc. Announces June Distribution

Toronto, June 24, 2025 (GLOBE NEWSWIRE) -- Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.

Cidara Announces Pricing of Upsized Public Offering of Common Stock

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the pricing of an underwritten public offering of 7,954,546 shares of its common stock at a price to the public of $44.00 per share. All of the shares are to be sold by Cidara.

NOTICE TO DISREGARD — Choice Renovations Canada Inc

Choice Renovations Canada partners with Fitzrovia to deliver fast, high-quality multifamily renovations across Toronto’s rental market.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.

JOYY Achieves Top Rankings in Extel’s 2025 Asia Executive Team Survey

SINGAPORE, June 25, 2025 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) ("JOYY" or the "Company"), a global technology company, has been acknowledged as a “Most Honored Company” by Extel, formerly known as Institutional Investor Research, in its 2025 Asia Companies' Executive Team Survey.

Hims & Hers Health, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Investigation

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of federal securities laws. Investors who purchased Hims & Hers securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.

- A word from our sponsors -

spot_img

Follow us